Figure 4From: Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistanceApproximate per-parasite probabilities of de-novo emergence of viable and transmissible resistant parasites in clinical infections. Mefloquine resistance results from Pfmdr amplification, pyrimethamine resistance from mutations in Pfdhfr, atovaquone resistance from mutations in Pfcyt b, and resistance to chloroquine from mutations in PfCRT.Back to article page